eGene Inc.'s HDA-GT12(TM) System Used By City of Hope National Medical Center For Automated HLA Genotyping For Genetic Matching Of Bone Marrow

IRVINE, Calif.--(BUSINESS WIRE)--Aug. 7, 2006--eGene Inc. (OTCBB:EGEI - News), developer of a revolutionary high-performance genetic analysis technology, announced today that HLA Laboratory in City of Hope National Medical Center (City of Hope, Calif.) has used eGene’s HDA-GT12(TM) System for automated HLA genotyping for matching of bone marrow transplants.

MORE ON THIS TOPIC